Interactions of nitrovasodilators, atrial natriuretic peptide and endothelium-derived nitric oxide

Journal of Vascular Research

Volumn 33, Issue 1, 1996, Pages 78-85

  Murohara, Toyoaki ^a   Kugiyama, Kiyotaka ^a   Yasue, Hirofumi ^a  

^a KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Coronary artery; Endothelium; Natriuretic peptide; Nitric oxide; Nitroglycerin tolerance

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRADYKININ; ENDOTHELIUM DERIVED RELAXING FACTOR; GLYCERYL TRINITRATE; ISOSORBIDE DINITRATE; NITRIC OXIDE; NITROPRUSSIDE SODIUM; VASODILATOR AGENT;

ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORONARY ARTERY; DRUG TOLERANCE; NONHUMAN; PRIORITY JOURNAL; SWINE; VASODILATATION;

EID: 0030066704     PISSN: 10181172     EISSN: 14230135     Source Type: Journal    
DOI: 10.1159/000159135     Document Type: Article

References (27)

1. Franciosa JA, Nordstrom LA, Cohn JN: Nitrate therapy for congestive heart failure, JAMA 1978:240:443-446.
2. McGregor M: The nitrates and myocardial ischemia, Circulation 1982:66:689-692.
3. Horowitz JD, Amman HM, Lorell BH, Barry WH, Smith TW: Potentiation of the cardiovascular effects of nitroglycerin by N-acctylcys-teine, Circulation 1983:68:1247-1253.
4. Parker M: What causes tolerance to nitroglyc-erin?The 100 year old mystery continues, Am J Cardiol 1990:16:932-935.
5. Dalai JJ, Parker JO: Nitrate cross-tolerance: Effect of sublingual isosorbide dinitrate and nitroglycerin during sustained nitrate therapy, Am J Cardiol 1984:54:286-288.
6. Abrams J: Clinical aspects of nitrate tolerance, Eur Heart J 1991:12(suppl E):E42-E52.
7. Henry PJ, Horowitz JD: Louis WJ: Nitroglycerin-induced tolerance affects multiple sites in the organic nitrate bioconversion cascade, J Pharmacol ExpTher 1989:248:762-768.
8. Necdleman P, Johnson EM: Mechanism of tolerance development to organic nitrates, J Pharmacol Exp Ther 1973:184:709-715.
9. Harrison DG, Bates JN: The nitrovasodilators, New ideas about old drugs, Circulation 1993; 87:1461-1467.
10. Ignarro LJ: Endothelium-derived nitric oxide: Pharmacology and relationship to the actions of organic nitrate esters, Pharm Res 1989:6: 651-659.
11. Ignarro LJ, Gruetter CA: Requirement of thiols for activation of coronary arterial guanylate cvclasc by glycerol trinitrate and sodium nitrite: Possible involvement of S-nitrosothiols, Biochim BiophysActa 1980:631:221-231.
12. Moncada S, Rees DD, Schulz R, Palmer MJ: Development and mechanism of a specific supersensitivity to nitrovasodilators after inhibition of vascular nitric oxide synthesis in vivo, Proc Natl Acad Sci USA 1991:88:2166-2170.
13. Palmer RMJ, Ferrige AG, Moncada S: Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor, Nature 1987:327:524-526.
14. Moncada S, Palmer RM, Higgs EA: Nitric oxide: Physiology, pathophysiology, and pharmacology, Pharmacol Rev 1991;43:109-142.
15. Furchgott RF, Vanhoutte PM: Endothelium-derived relaxing and contracting factors, FASEBJ 1989:3:2007-2018.
16. Arnold WP, Mittal CK, Katsuki S, Murad F: Nitric oxide activates guanylate cyclase and increases guanosine 3':5'-cyclic monophosphate levels in various tissue preparations, Proc Natl Acad Sci USA 1977:74:3203-3207.
17. Dc Bold AJ: Atrial natriuretic factor: A hormone produced by the heart, Science 1985:230: 767-769.
18. Saito Y, Nakao K, Nishimura K, Sugawara A, Okumura K, Obata K, Sonoda R, Ban T, Yasue H, Imura H: Clinical application of atrial natriuretic polypeptide in patients with congestive heart failure: Beneficial effects on left ventricular function, Circulation 1987;76:115-124.
19. Lai C-P, Egashira K, Tashiro H, Narabavashi H, Koyanagi S, Imaizumi T, Takcshita A: Beneficial effects of atrial natriuretic peptide on exercise-induced myocardial ischemia in patients with stable elTort angina pectoris, Circulation 1993:87:144-151.
20. Tanaka H, Yasue H, Yoshimura M, Morita E, Jougasaki M, Kato H, Miyao Y, Nakao K: Suppression of hyperventilation-induced attacks with infusion of atrial natriuretic peptide in patients with variant angina pectoris, Am J Cardiol 1993:72:128-133.
21. Waldman SA, Rapoport RM, Murad F: Atrial natriuretic factor selectively activates particulate guanylate cyclase and elevates cyclic GMP in rat tissues, J Biol Chem 1984.259:14332-14334.
22. Dineman JL, Lawson DL, Mehta JL: Interactions between nitroglycerin and endothelium in vascular smooth muscle relaxation, Am J Physiol 1991:260:H698-H701.
23. Anderson TJ, Meredith IT, Ganz P, Sclwvn AP, Yeung AC: Nitric oxide and nitrovasodilators: Similarities, differences and potential interactions, J Am Coll Cardiol 1994.24:555-566.
24. Rapoport RM, Waldman SA, Schwartz K, Winquist RJ, Murad F: Effects of atrial natriuretic factor, sodium nitroprusside, and acetylcholine on cyclic GMP levels and relaxation in rataor, a, EurJ Pharmacol 1985:115.219-229.
25. Matsumoto T, Okamura T, Kinoshita M, Toda N: Interactions of nitrovasodilators and atrial natriuretic peptide in isolated dog coronar> arteries, EurJ Pharmacol 1993.237:31-37.
26. I lirata K, Akita H, Yokoyama M, Watanabe Y: Impaired vasodilator)’ response to atrial natriuretic peptide during atherosclerosis progression, Artcrioscler Thromb 1992:12:99-105.
27. Buga GM, Griscavagc JM, Rogers NE, Ignarro U: Negative feedback regulation of endothelial cell function by nitric oxide, Circ Res 1993:73: 808-812.